Form 4 for GILD Gilead Sciences

Accepted 2024-07-26 00:00:00 ET · period of report 2024-07-25 · accession 0001127602-24-021048 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2024-07-26	2024-07-25	GILD	Telman Deborah H	EVP, GC, Corp. Affairs	M - OptEx	—	+8,744	12.1K	+257%	—
D	2024-07-26	2024-07-25	GILD	Telman Deborah H	EVP, GC, Corp. Affairs	F - Tax	$76.51	-2,917	11.6K	-20%	-$223.2K
DM	2024-07-26	2024-07-25	GILD	Telman Deborah H	EVP, GC, Corp. Affairs	M - OptEx	—	-8,744	30.2K	-22%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-07-25	M	A	8,230	—	20,375	D	—	—	(F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2	Common	Common Stock	2024-07-25	M	A	514	—	12,145	D	—	—	(F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3	Common	Common Stock	2024-07-25	F	D	2,917	$76.51	11,631	D	—	—
4	Derivative	Restricted Stock Unit	2024-07-25	M	D	514	—	38,416	D	— · — to —	514 Common Stock	(F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
5	Derivative	Restricted Stock Unit	2024-07-25	M	D	8,230	—	30,186	D	— · — to —	8,230 Common Stock	(F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested.